+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Discovery and Innovation Award

Western New York BloodCare

This program has been established to promote, nurture and amplify scientific discovery and innovation in Western New York and the region. The WNYBC Discovery and Innovation Award will support basic, translational, and/or clinical research projects that will improve health outcomes, health equity, and/or preventing complications of hemophilia and/or hemostatic or thrombotic disorders.

The program invites proposals from higher education institutions and non-profit organizations that have a history and track record of serving the community of bleeding and clotting disorders. There is no age requirement, however, applicants must have an MD, PhD or equivalent; clearly state they have both independent research projects and independent resources; and have preliminary results/and or publications from their independent laboratory.

Grant Application Details

Budget must not exceed $150,000/year, for up to three years. Up to two grants will be awarded annually.

APPLICATION DUE DATE: July 1, 2025

GRANT START DATE: January 1, 2026

AI Based Application Success Predictor

1. Strong Independent Research Profile

PI must hold an MD/PhD (or equivalent) and demonstrate independent projects and resources, including preliminary data or peer-reviewed publications from their own lab .

Having an ongoing independent lab and track record is critical for credibility and readiness.

🧬 2. Alignment with Mission‑Focused Priorities

Projects must address hemophilia or related hemostatic/thrombotic disorders, such as joint disease, inhibitors, von Willebrand disease, women’s bleeding disorders, diagnostics, or novel therapeutics .

Emphasis is on improving health outcomes, health equity, and preventing complications—proposals aligning here are prioritized.

🤝 3. Meaningful Collaboration & Diversity

Priority is given to teams collaborating with a Hemophilia Treatment Center, and those that promote diversity in staffing or patient populations .

Regional or community partnerships are valued.

🏥 4. Training Component

Projects need to include training opportunities for physician–scientists or biomedical researchers .

Mentorship depth and workforce development are important evaluative criteria.

💰 5. Realistic Project Scope & Budget Discipline

Budget capped at $150K/year (3 years max) with ≤10% indirect costs and PI salary ≤5% effort .

Requests should clearly justify funds for salary, supplies, equipment, or technical assistance—not infrastructure or rent.

📊 6. Commitment to Outcomes & Reporting

Applicants must commit to biannual progress reports, presentation at the RTI annual symposium, and acknowledgment of funding in all outputs .

Demonstrating capacity to meet deliverables (e.g., publications, conference presentations) is essential.

🧭 Strategy Summary

Success Factor	How to Integrate it
Independent Data & Productivity	Provide pilot data, papers, and lab overview showing capability.
Mission-Alignment	Explicitly link aims to hemophilia/bleeding‑disorder outcomes and equity.
Collaborative Network & Inclusion	Partner with a HTC, include diverse team members and populations.
Training Plan	Include roles for trainees and define mentorship structure.
Budget Clarity	Stick strictly to funding limits and permissible costs.
Outcomes Orientation	Outline metrics, publication/presentation plans, and reporting readiness.

✅ Final Advice

To boost your chances:

Show you're fully independent, productive, and capable of executing the work.

Align deeply with WNYBC’s research priorities and regional mission.

Add collaboration with local HTC and a clear diversity plan.

Embed training and mentorship within your project.

Respect budget constraints and cost categories.

Highlight outcomes reporting capacity and commitment to share findings.

Specialties

Hematology

Eligibility Requirements

applicants must have an MD, PhD or equivalent; clearly state they have both independent research projects and independent resources; and have preliminary results/and or publications from their independent laboratory.

Sponsor Details

Sponsor Institute/Organizations: Western New York BloodCare

Sponsor Type: Corporate/Non-Profit

Address: 1010 Main St suite 300, Buffalo, NY 14202

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity